Clinical chemistry/immunoassay analyzers
Ended Awarded Last action
- Contract number
- HT940623F0005
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,765,306
Award facts
- Contract value 76% obligated
-
- $2,765,306.39 Current, with exercised options
- $3,617,878.41 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $730,776 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Funding Only Action | $718,070 | |
| Exercise an Option | $0 | |
| Funding Only Action | $718,070 | |
| Exercise an Option | $0 | |
| Original award | $598,391 |
About this award
Roche Diagnostics Corporation received a $3.62 million delivery order from the Defense Health Agency on December 1, 2022, for clinical chemistry and immunoassay analyzers with performance extending through September 30, 2027. This firm fixed-price contract, awarded without set-aside designation, represents a child order under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III) and leverages Roche's established relationship with the Defense Health Agency for diagnostic laboratory equipment and services. The place of performance is Castleton, Indiana, where Roche Diagnostics Corporation maintains significant operations as a leading global provider of in vitro diagnostic solutions and laboratory instrumentation to federal healthcare systems.
This award aligns with the Defense Health Agency's ongoing requirement to maintain and expand clinical laboratory diagnostic capabilities across military treatment facilities and the military healthcare system. Roche Diagnostics has demonstrated substantial federal contracting experience across the Department of Veterans Affairs, Defense Health Agency, and other federal healthcare agencies, with multiple active indefinite delivery contracts and blanket purchase agreements valued in the tens of millions of dollars. The company's portfolio includes molecular diagnostic analyzers, histology staining systems, immunochemistry platforms, and comprehensive maintenance and support services, positioning it as a primary supplier of advanced diagnostic technologies to military and federal healthcare infrastructure.
Quick answers
Who was awarded contract HT940623F0005?
HT940623F0005 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on December 1, 2022.
How much is contract HT940623F0005 worth?
The government has obligated $2,765,306 on HT940623F0005. Its potential value, with all options, is $3,617,878.
Is contract HT940623F0005 an order under another contract?
Yes. HT940623F0005 is a delivery order under V797P7347A, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract HT940623F0005 competed?
The extent of competition for HT940623F0005 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award